Download PDF
Z Gastroenterol 2016; 54(10): 1168-1169
DOI: 10.1055/s-0042-113194
Kommentar
© Georg Thieme Verlag KG Stuttgart · New York

Stressulkusprophylaxe: Sind PPIs den H2-Rezeptorantagonisten wirklich überlegen?

Stress ulcer prophylaxis: are PPIs truly superior compared to H2 receptor antagonists?
H. M. Steffen
Further Information

Publication History

22 May 2016

22 July 2016

Publication Date:
10 October 2016 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Die S2k-Leitlinie „Helicobacter pylori und gastroduodenale Ulkuskrankheit“ enthält zum Thema Stressulkusprophylaxe eine Empfehlung/ein Statement mit zugehörigem Kommentar, die kritisch hinterfragt werden sollten.

Abstract

The S2k-Guideline “Helicobacter pylori and gastroduodenal ulcer disease” offers a statement and comment on the subject of stress ulcer prophylaxis that need a critical response.

Schlüsselwörter

Stressulkusprophylaxe - Protonenpumpeninhibitoren - H2-Rezeptorantagonisten

Key words

stress ulcer prophylaxis - proton pump inhibitors - H2 receptor antagonists
 

  • Literatur

  • 1 Fischbach W et al. S2k-Leitlinie Helicobacter pylori und gastroduodenale Ulkuskrankheit. Z Gastroenterol 2016; 54: 327-363
    Article in Thieme ConnectPubMedGoogle Scholar
  • 2 Fischbach W et al. S3-Leitlinie „Helicobacter pylori und gastroduodenale Ulkuskrankheit“ der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten (DGVS) in Zusammenarbeit mit der Deutschen Gesellschaft für Hygiene und Mikrobiologie, Gesellschaft für Pädiatrische Gastroenterologie und Ernährung e.V. und der Deutschen Gesellschaft für Rheumatologie – AWMF-Register-Nr. 021/001. Z Gastroenterol 2009; 47: 68-102
    Article in Thieme ConnectPubMedGoogle Scholar
  • 3 Marik PE et al. Stress ulcer prophylaxis in the new millennium: a systematic review and meta-analysis. Crit Care Med 2010; 38: 2222-2228
    CrossrefPubMedGoogle Scholar
  • 4 Alhazzani W et al. Proton pump inhibitors versus histamine 2 receptor antagonists for stress ulcer prophylaxis: a systematic review and meta-analysis. Crit Care Med 2013; 41: 693-705
    CrossrefPubMedGoogle Scholar
  • 5 Krag M et al. Stress ulcer prophylaxis versus placebo or no prophylaxis in critically ill patients. A systematic review of randomised clinical trials with meta-analysis and trial sequential analysis. Intensive Care Med 2014; 40: 11-22
    CrossrefPubMedGoogle Scholar
  • 6 Liu B et al. Risks and benefits of stress ulcer prophylaxis in adult neurocritical care patients: a systematic review and meta-analysis of randomized controlled trials. Crit Care 2015; 19: 409 DOI: 10.1186/s13054-015-1107-2.
    CrossrefPubMedGoogle Scholar
  • 7 Buendgens L et al. Administration of proton pump inhibitors in critically ill medical patients is associated with increased risk of developing Clostridium dificile-associated diarrhea. J Crit Care 2014; 29: 696.e11-696.e15
    CrossrefPubMedGoogle Scholar
  • 8 Dellinger RP et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013; 41: 580-637
    CrossrefPubMedGoogle Scholar
  • 9 Bardou M et al. Stress-related mucosal disease in the critically ill patient. Nat Rev Gastroenterol Hepatol 2015; 12: 98-107
    CrossrefPubMedGoogle Scholar
  • 10 MacLaren R et al. Histamine-2 receptor antagonists vs proton pump inhibitors on gastrointestinal tract hemorrhage and infectious complications in the intensive care unit. JAMA Intern Med 2014; 174: 564-574
    CrossrefPubMedGoogle Scholar
  • 11 Kwok CS et al. Risk of Clostridium difficile infection with acid suppressing drugs and antibiotics: meta-analysis. Am J Gastroenterol 2012; 107: 1011-1019
    CrossrefPubMedGoogle Scholar